Yıl: 2021 Cilt: 32 Sayı: 3 Sayfa Aralığı: 240 - 247 Metin Dili: İngilizce DOI: 10.5152/tjg.2021.191034 İndeks Tarihi: 24-05-2022

Outcomes of Pediatric Fistulising Perianal Crohn’s Disease

Öz:
Background: Perianal disease is reported more widely in pediatric Crohn patients than in the past, and has been stated as an independent modifier of the disease behavior. In this study, we aimed to analyze the clinical characteristics and outcomes of fistulising perianal Crohn’s disease (fpCD) in the pediatric age group. Methods: A total number of 149 children with an established diagnosis of inflammatory bowel disease who have been diagnosed before 18 years of age and followed in our tertiary center were revised. Clinical, endoscopic, laboratory, and radiologic data of 50 patients with CD, who had at least 18 months follow-up data, were compiled. Results: Of 50 patients, 26 (52%) were diagnosed as fpCD (38% at onset). More than half of the patients without any notable external orifices around the perianal area were diagnosed as fpCD by an magnetic resonance imaging (MRI). Pediatric fpCD patients had a higher disease activity score and platelet count, lower serum albumin level, and a higher rate of granuloma in the biopsy samples, compared with non-fistulising patients. A considerably high rate of surgical interventions (i.e., seton placement 46% and abscess drainage 15%) was performed in combination with infliximab. Conclusion: Fistulising perianal Crohn’s disease seems to be more common than previously reported in the pediatric age group. A severe course of the disease might serve as a warning for the development of fpCD. A careful physical examination and use of perianal MRI with a high index of suspicion may increase the likelihood of fistula detection, hence may change the treatment strategy.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014;8(10):1179-1207. [CrossRef]
  • 2. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135(4):1114-1122. [CrossRef]
  • 3. Pigneur B, Seksik P, Viola S, et al. Natural history of Crohn’s disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis. 2010;16(6):953-961. [CrossRef]
  • 4. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314-1321. [CrossRef]
  • 5. Sica GS, Di Carlo S, Tema G, et al. Treatment of peri-anal fistula in Crohn’s disease. World J Gastroenterol. 2014;20(37):13205-13210. [CrossRef]
  • 6. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn’s disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103(12):3082-3093. [CrossRef]
  • 7. Freeman HJ. Comparison of longstanding pediatric-onset and adult-onset Crohn’s disease. J Pediatr Gastroenterol Nutr. 2004;39(2):183-186. [CrossRef]
  • 8. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143(4):525-531. [CrossRef]
  • 9. Herman Y, Rinawi F, Rothschild B, Nir O, Shamir R, Assa A. The characteristics and long-term outcomes of pediatric Crohn’s disease patients with perianal disease. Inflamm Bowel Dis. 2017;23(9):1659- 1665. [CrossRef]
  • 10. de Zoeten EF, Pasternak BA, Mattei P, Kramer RE, Kader HA. Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr. 2013;57(3):401-412. [CrossRef]
  • 11. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63(9):1381-1392. [CrossRef]
  • 12. Parks AG, Gordon PH, Hardcastle JD. A classification of fistulain-ano. Br J Surg. 1976;63(1):1-12. [CrossRef]
  • 13. Van Assche G, Vanbeckevoort D, Bielen D et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol. 2003;98(2):332-339. [CrossRef]
  • 14. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439-447. [CrossRef]
  • 15. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn’s disease. Gastroenterology. 2006;130(3):650-656. [CrossRef]
  • 16. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795-806. [CrossRef]
  • 17. Keljo DJ, Markowitz J, Langton C, et al. Course and treatment of perianal disease in children newly diagnosed with Crohn’s disease. Inflamm Bowel Dis. 2009;15(3):383-387. [CrossRef]
  • 18. Zwintscher NP, Shah PM, Argawal A, et al. The impact of perianal disease in young patients with inflammatory bowel disease. Int J Colorectal Dis. 2015;30(9):1275-1279. [CrossRef]
  • 19. Brückner A, Werkstetter KJ, de Laffolie J, et al. Incidence and risk factors for perianal disease in pediatric Crohn’s disease patients followed in CEDATA-GPGE registry. J Pediatr Gastroenterol Nutr. 2018;66(1):73-78. [CrossRef]
  • 20. Assa A, Amitai M, Greer ML, et al. Perianal pediatric Crohn’s disease is associated with a distinct phenotype and greater inflammatory burden. J Pediatr Gastroenterol Nutr. 2017;65(3):293-298. [CrossRef]
  • 21. Adler J, Dong S, Eder SJ, Dombkowski KJ, ImproveCareNow Pediatric IBD Learning Health System. Perianal Crohn disease in a Large Multicenter Pediatric Collaborative. J Pediatr Gastroenterol Nutr. 2017;64(5):e117-e124. [CrossRef]
  • 22. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn’s disease: a population-based cohort study. Gastroenterology. 2008;135(4):1106-1113. [CrossRef]
  • 23. de Bie CI, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;19(2):378-385. [CrossRef]
  • 24. Singer AA, Gadepalli SK, Eder SJ, Adler J. Fistulizing Crohn’s disease presenting after surgery on a perianal lesion. Pediatrics. 2016;137(3):e20152878. [CrossRef]
  • 25. Short SS, Dubinsky MC, Rabizadeh S, Farrior S, Berel D, Frykman PK. Distinct phenotypes of children with perianal perforating Crohn’s disease. J Pediatr Surg. 2013;48(6):1301-1305. [CrossRef]
  • 26. Rothschild B, Rinawi F, Herman Y, Nir O, Shamir R, Assa A. Prognostic significance of granulomas in children with Crohn’s disease. Scand J Gastroenterol. 2017;52(6-7):716-721. [CrossRef]
  • 27. Heresbach D, Alexandre JL, Branger B, et al. ABERMAD (Association Bretonne d’Etude et de Recherche sur les Maladies de l’Appareil Digestif ). Gut. 2005;54(2):215-222. [CrossRef]
  • 28. Denoya P, Canedo J, Berho M, et al. Granulomas in Crohn’s disease: does progression through the bowel layers affect presentation or predict recurrence? Colorectal Dis. 2011;13(10):1142-1147. [CrossRef]
  • 29. Kaur M, Panikkath D, Yan X, et al. Perianal Crohn’s disease is associated with distal colonic disease, stricturing disease behavior, IBD-associated serologies and genetic variation in the JAK-STAT pathway. Inflamm Bowel Dis. 2016;22(4):862-869. [CrossRef]
  • 30. Gupta N, Cohen SA, Bostrom AG, et al. Risk factors for initial surgery in pediatric patients with Crohn’s disease. Gastroenterology. 2006;130(4):1069-1077. [CrossRef]
APA ŞAHİN AKKELLE B, Kalaycik Sengul O, Volkan B, Tutar E, Ergelen R, Yardımcı S, Ertem D (2021). Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. , 240 - 247. 10.5152/tjg.2021.191034
Chicago ŞAHİN AKKELLE BİLGE,Kalaycik Sengul Ozlem,Volkan Burcu,Tutar Engin,Ergelen Rabia,Yardımcı Samet,Ertem Deniz Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. (2021): 240 - 247. 10.5152/tjg.2021.191034
MLA ŞAHİN AKKELLE BİLGE,Kalaycik Sengul Ozlem,Volkan Burcu,Tutar Engin,Ergelen Rabia,Yardımcı Samet,Ertem Deniz Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. , 2021, ss.240 - 247. 10.5152/tjg.2021.191034
AMA ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. . 2021; 240 - 247. 10.5152/tjg.2021.191034
Vancouver ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. . 2021; 240 - 247. 10.5152/tjg.2021.191034
IEEE ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D "Outcomes of Pediatric Fistulising Perianal Crohn’s Disease." , ss.240 - 247, 2021. 10.5152/tjg.2021.191034
ISNAD ŞAHİN AKKELLE, BİLGE vd. "Outcomes of Pediatric Fistulising Perianal Crohn’s Disease". (2021), 240-247. https://doi.org/10.5152/tjg.2021.191034
APA ŞAHİN AKKELLE B, Kalaycik Sengul O, Volkan B, Tutar E, Ergelen R, Yardımcı S, Ertem D (2021). Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. Turkish Journal of Gastroenterology, 32(3), 240 - 247. 10.5152/tjg.2021.191034
Chicago ŞAHİN AKKELLE BİLGE,Kalaycik Sengul Ozlem,Volkan Burcu,Tutar Engin,Ergelen Rabia,Yardımcı Samet,Ertem Deniz Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. Turkish Journal of Gastroenterology 32, no.3 (2021): 240 - 247. 10.5152/tjg.2021.191034
MLA ŞAHİN AKKELLE BİLGE,Kalaycik Sengul Ozlem,Volkan Burcu,Tutar Engin,Ergelen Rabia,Yardımcı Samet,Ertem Deniz Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. Turkish Journal of Gastroenterology, vol.32, no.3, 2021, ss.240 - 247. 10.5152/tjg.2021.191034
AMA ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. Turkish Journal of Gastroenterology. 2021; 32(3): 240 - 247. 10.5152/tjg.2021.191034
Vancouver ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D Outcomes of Pediatric Fistulising Perianal Crohn’s Disease. Turkish Journal of Gastroenterology. 2021; 32(3): 240 - 247. 10.5152/tjg.2021.191034
IEEE ŞAHİN AKKELLE B,Kalaycik Sengul O,Volkan B,Tutar E,Ergelen R,Yardımcı S,Ertem D "Outcomes of Pediatric Fistulising Perianal Crohn’s Disease." Turkish Journal of Gastroenterology, 32, ss.240 - 247, 2021. 10.5152/tjg.2021.191034
ISNAD ŞAHİN AKKELLE, BİLGE vd. "Outcomes of Pediatric Fistulising Perianal Crohn’s Disease". Turkish Journal of Gastroenterology 32/3 (2021), 240-247. https://doi.org/10.5152/tjg.2021.191034